Pacific Biosciences of California, Inc. Standard and Extended Product Warranty Accrual, Decrease for Payments
Pacific Biosciences of California, Inc. (PACB) reported Standard and Extended Product Warranty Accrual, Decrease for Payments of $1.24 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Product Warranties Disclosures
us-gaap:ProductWarrantyAccrualPayments · last filed 2026-08-06
- Pacific Biosciences of California, Inc. standard and extended product warranty accrual, decrease for payments for the quarter ending 2026-06-30 was $1.24M, a 12.64% decline year-over-year.
- Pacific Biosciences of California, Inc. standard and extended product warranty accrual, decrease for payments for the quarter ending 2026-03-31 was $1.69M, a 8.83% increase year-over-year.
- Pacific Biosciences of California, Inc. standard and extended product warranty accrual, decrease for payments for the quarter ending 2025-12-31 was $1.25M, a 17.60% decline year-over-year.
- Pacific Biosciences of California, Inc. standard and extended product warranty accrual, decrease for payments for the quarter ending 2025-09-30 was $1.38M, a 14.04% decline year-over-year.
- Pacific Biosciences of California, Inc. standard and extended product warranty accrual, decrease for payments for fiscal 2025 was $5.61M, a 27.40% decline from fiscal 2024.
- Pacific Biosciences of California, Inc. standard and extended product warranty accrual, decrease for payments for fiscal 2024 was $7.72M, a 48.64% increase from fiscal 2023.
- Pacific Biosciences of California, Inc. standard and extended product warranty accrual, decrease for payments for fiscal 2023 was $5.20M, a 142.62% increase from fiscal 2022.
- Pacific Biosciences of California, Inc. standard and extended product warranty accrual, decrease for payments for fiscal 2022 was $2.14M, a 26.97% increase from fiscal 2021.
| Period end | Standard and Extended Product Warranty Accrual, Decrease for Payments 3 month | Standard and Extended Product Warranty Accrual, Decrease for Payments 6 month | Standard and Extended Product Warranty Accrual, Decrease for Payments 9 month | Standard and Extended Product Warranty Accrual, Decrease for Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.24M 10-Q · filed 2026-08-06 | $2.93M 10-Q · filed 2026-08-06 | $4.18M derived: sum of 3 quarters · filed 2026-08-06 | $5.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.69M 10-Q · filed 2026-05-08 | $2.94M derived: sum of 2 quarters · filed 2026-05-08 | $4.33M derived: sum of 3 quarters · filed 2026-05-08 | $5.74M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.64M derived: sum of 2 quarters · filed 2026-02-25 | $4.05M derived: sum of 3 quarters · filed 2026-08-06 | $5.61M 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.38M 10-Q · filed 2025-11-06 | $2.80M derived: sum of 2 quarters · filed 2026-08-06 | $4.35M 10-Q · filed 2025-11-06 | $5.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.42M 10-Q · filed 2026-08-06 | $2.97M 10-Q · filed 2026-08-06 | $4.49M derived: sum of 3 quarters · filed 2026-08-06 | $6.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.55M 10-Q · filed 2026-05-08 | $3.08M derived: sum of 2 quarters · filed 2026-05-08 | $4.68M derived: sum of 3 quarters · filed 2026-05-08 | $7.12M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.13M derived: sum of 2 quarters · filed 2026-02-25 | $5.56M derived: sum of 3 quarters · filed 2026-02-25 | $7.72M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.61M 10-Q · filed 2025-11-06 | $4.04M derived: sum of 2 quarters · filed 2025-11-06 | $6.20M 10-Q · filed 2025-11-06 | $8.04M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $2.43M 10-Q · filed 2025-08-07 | $4.59M 10-Q · filed 2025-08-07 | $6.43M derived: sum of 3 quarters · filed 2025-08-07 | $8.15M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $2.16M 10-Q · filed 2025-05-12 | $4.00M derived: sum of 2 quarters · filed 2025-05-12 | $5.72M derived: sum of 3 quarters · filed 2025-05-12 | $6.73M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $3.56M derived: sum of 2 quarters · filed 2025-03-17 | $4.57M derived: sum of 3 quarters · filed 2025-03-17 | $5.20M 10-K · filed 2025-03-17 |
| 2023-09-30 | $1.72M 10-Q · filed 2024-11-12 | $2.73M derived: sum of 2 quarters · filed 2024-11-12 | $3.36M 10-Q · filed 2024-11-12 | $4.03M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.01M 10-Q · filed 2024-08-09 | $1.64M 10-Q · filed 2024-08-09 | $2.31M derived: sum of 3 quarters · filed 2024-08-09 | $2.93M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $631.00K 10-Q · filed 2024-05-09 | $1.30M derived: sum of 2 quarters · filed 2024-05-09 | $1.92M derived: sum of 3 quarters · filed 2024-05-09 | $2.40M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $670.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.29M derived: sum of 2 quarters · filed 2024-02-28 | $1.77M derived: sum of 3 quarters · filed 2024-02-28 | $2.14M 10-K · filed 2024-02-28 |
| 2022-09-30 | $622.00K 10-Q · filed 2023-11-03 | $1.10M derived: sum of 2 quarters · filed 2023-11-03 | $1.47M 10-Q · filed 2023-11-03 | $1.97M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $477.00K 10-Q · filed 2023-08-04 | $850.00K 10-Q · filed 2023-08-04 | $1.35M derived: sum of 3 quarters · filed 2023-08-04 | $2.03M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $373.00K 10-Q · filed 2023-05-04 | $872.00K derived: sum of 2 quarters · filed 2023-05-04 | $1.55M derived: sum of 3 quarters · filed 2023-05-04 | $1.88M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $499.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.18M derived: sum of 2 quarters · filed 2023-02-28 | $1.50M derived: sum of 3 quarters · filed 2023-02-28 | $1.69M 10-K · filed 2023-02-28 |
| 2021-09-30 | $683.00K 10-Q · filed 2022-11-08 | $1.00M derived: sum of 2 quarters · filed 2022-11-08 | $1.19M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $320.00K 10-Q · filed 2022-08-08 | $505.00K 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |